ANI
07 Dec 2022, 19:55 GMT+10
Beijing [China], December 7 (ANI): During the initial outbreak of Covid-19, China discouraged the use of international vaccines Moderna and Pfizer instead promoted its domestic product Sincovac. Repeated explosive outbreaks of Covid in China along with tested and proven lack of effectiveness of its vaccines, has created a problem for its own citizens and people around the world, The Singapore Post, a news outlet with an online portfolio reported.
The Singapore Post reported, "Recent studies show that Chinese vaccines such as Sinovac have only been effective up to 61% against deaths and 55% against hospitalization, while Moderna and Pfizer fared much better at 90% protection from both."Moreover, when global manufacturers were concentrating on producing vaccines China was busy defaming and running propaganda against the effectiveness of mRNA vaccines as per The Singapore Post report.
Traditional vaccines implanted a weakened or inactivated germ into our bodies, however, the mRNA vaccines, teach cells how to make a protein that triggers an immune response if someone gets infected, the report says. A study by Lancet indicated that Sincovac was producing weaker T-cell vaccines and was not able to provide protection against the deadly virus.
Research like this raised concerns in the general public resulting in mass rejection of China's vaccines by the general public, and hence the Chinese authorities were not able to vaccinate its large population which finally led to an extreme Zero Covid policy.
Countries like Turkey which accepted China's vaccines CoronaVac by Sincovac Biotech were not received well by their local population due to disbelief in Chinese research and the cases of data tampering that china had been involved in just to sell its vaccines internationally, according to The Singapore Post.
Indonesia in December 2020 had given statements that they had received 97 per cent efficacy in Chinese vaccines. Although they changed their statement in 2021 stating its efficacy was a mere 65 per cent. Similarly, Brazil's declaration of the Chinese product's efficacy was at 78 per cent but later changed to 50.4 per cent, The Singapore Post reported.
Thailand and Indonesia also revoked the Chinese vaccines that they were giving to the general public and replaced them with AstraZeneca. Although, for its healthcare workers, Moderna jabs were arranged as they were facing deaths even after being fully vaccinated by Sincovac's vaccine. Malaysia also later announced that it will also replace its vaccines with Pfizer vaccines soon, as reported by The Singapore Post.
As per the report, all these attempts at data tampering ultimately were unable to hide the inability of Chinese vaccines to provide protection against the disease. But now that the vaccine has reached the international market it has become a problem across the boundaries of China which has resulted in the worsening of China's already dented image globally, reported The Singapore Post. (ANI)
Get a daily dose of Brazil Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Brazil Sun.
More InformationAbu Dhabi [UAE], February 7 (ANI): Indian tennis player Sania Mirza and her American doubles partner Bethanie Mattek-Sands crashed out ...
New Delhi [India], February 6 (ANI): External Affairs Minister S Jaishankar met with the science and technology minister of Argentina ...
Lima, Peru - The government of Peru on Sunday expanded and prolonged a state of emergency to deal with a ...
Milan [Italy], February 6 (ANI): Lautaro Martinez continued his brilliant start to the year as he helped Inter Milan register ...
Finland highlighted the close of the Davis Cup qualifying series on Sunday, downing Argentina 3-1 to secure its first-ever berth ...
SANTIAGO, CHILE - Firefighters were battling dozens of raging wildfires in Chile on Sunday, seeking to gain control of one ...
NEW YORK, New York - A sharp rise in U.S. Treasury yields kept buyers at bay on Wall Street on ...
WASHINGTON D.C.: A report released this week detailed how, in January, layoffs in the US reached a more than two-year ...
PARIS, France: Following an 18 month controversy that exposed the workings of the global jet market, Airbus and Qatar Airways ...
TOKYO, Japan: Japan is preparing to revise legislation to allow it to restrict the export of advanced semiconductor manufacturing equipment ...
LONDON, England: Energy giant Shell Oil has announced a record profit of nearly $40 billion in 2022, capping an eventful ...
TOKYO, Japan: Honda has announced that it will manufacture a new hydrogen fuel cell system, which was jointly developed with ...